AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 129 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $6,918,000 | +275.4% | 115,600 | +76.2% | 0.02% | +240.0% |
Q3 2019 | $1,843,000 | -10.2% | 65,600 | +21.0% | 0.01% | -16.7% |
Q2 2019 | $2,052,000 | -0.8% | 54,200 | +2.3% | 0.01% | 0.0% |
Q1 2019 | $2,068,000 | +189.6% | 53,000 | +58.2% | 0.01% | +200.0% |
Q4 2018 | $714,000 | -44.7% | 33,500 | +2.8% | 0.00% | -50.0% |
Q3 2018 | $1,291,000 | +3.6% | 32,600 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,246,000 | +276.4% | 32,600 | +196.4% | 0.00% | +300.0% |
Q1 2018 | $331,000 | -3.8% | 11,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $344,000 | +11.7% | 11,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $308,000 | +46.7% | 11,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $210,000 | – | 11,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |